Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial

Ghia, Paolo, Coutre, Steven E, Cheson, Bruce D, Barrientos, Jacqueline C, Hillmen, Peter, Pettitt, Andrew R, Zelenetz, Andrew D, Shreay, Sanatan, Hallek, Michael and Furman, Richard R (2020) Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial. HAEMATOLOGICA, 105 (10). E519-E522.

Text GIL171005B_116 PRO letter_R1_draft 1_2019 11 08.docx - Author Accepted Manuscript Download (365kB)

Item Type:	Article
Uncontrolled Keywords:	Humans, Purines, Antineoplastic Combined Chemotherapy Protocols, Quality of Life, Quinazolinones, Leukemia, Lymphocytic, Chronic, B-Cell
Depositing User:	Symplectic Admin
Date Deposited:	10 Jun 2020 07:49
Last Modified:	02 Feb 2023 01:37
DOI:	10.3324/haematol.2019.238808
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3089893